From: Overexpression of Cullin7 is associated with hepatocellular carcinoma progression and pathogenesis
Parameter | n | Cullin7 | ||
---|---|---|---|---|
negative(%) | positive(%) | P | ||
Sex | ||||
āMale | 144 | 44(30.6) | 100(69.4) | 0.810 |
āFemale | 18 | 6(33.3) | 12(66.7) | Ā |
Age(years) | ||||
ā<50 | 97 | 32(33.0) | 65(67.0) | 0.474 |
āāā„ā50 | 65 | 18(27.7) | 47(72.3) | Ā |
Tumor size(cm) | ||||
ā<5 | 90 | 29(32.2) | 61(67.8) | 0.676 |
āāā„ā5 | 72 | 21(29.2) | 51(70.8) | Ā |
Tumor numbers | ||||
āSingle | 116 | 34(29.3) | 82(70.7) | 0.497 |
āmultitude | 46 | 16(34.8) | 30(65.2) | Ā |
AFP(Ī¼g/L) | ||||
ā<400 | 98 | 31(31.6) | 67(68.4) | 0.793 |
āāā„ā400 | 64 | 19(29.7) | 45(70.3) | Ā |
HBsAg | ||||
āpositive | 135 | 41(30.4) | 94(69.6) | 0.761 |
ānegative | 27 | 9(33.3) | 18(66.7) | Ā |
Tumor thrombus | ||||
āhave | 69 | 11(15.9) | 58(84.1) | 0.000 |
āno | 93 | 39(41.9) | 54(58.1) | Ā |
Lymph metastasis | ||||
āhave | 33 | 5(15.2) | 28(84.8) | 0.029 |
āno | 129 | 45(34.9) | 84(65.1) | Ā |
Pathological grade | ||||
āhigh | 37 | 12(32.4) | 25(67.6) | 0.780 |
āmoderately | 112 | 33(29.5) | 79(70.5) | Ā |
ālow | 13 | 5(38.5) | 8(61.5) | Ā |
Hepatic function | ||||
āChild A | 106 | 34(32.1) | 72(67.9) | 0.820 |
āChild B | 36 | 11(30.6) | 25(69.4) | Ā |
āChild C | 20 | 5(25.0) | 15(75.0) | Ā |
Clinical stage | ||||
āA | 64 | 30(46.9) | 34(53.1) | 0.001 |
āB | 11 | 5(45.5) | 6(54.5) | Ā |
āC | 67 | 12(17.9) | 55(82.1) | Ā |
āD | 20 | 3(15.0) | 17(85.0) | Ā |